Ampio enrolling patients for inhalable COVID-19 Phase I trial
The immunotherapy-focused firm reports enrollment stands at 55% for its ongoing study exploring viability of Ampion as an inhalable COVID-19 treatment.
Archives for January 14, 2021
Sanofi unveils EUROAPI as name of new API company
The global pharmaceutical firm expects big things from its newly formed active pharmaceutical ingredients company, to be led by new CEO Karl Rotthier.